Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1

Biochemical and Biophysical Research Communications
D BacquevilleM Breton-Douillon

Abstract

In the present study, we investigated the involvement of phosphatidylinositol 3-kinase (PI 3-kinase) activity in the progression of vascular smooth muscle cells (VSMCs) throughout the G1 phase of cell cycle. Addition of two selective inhibitors of PI 3-kinase, LY 294002 or wortmannin, to quiescent VSMCs prevented serum-induced DNA synthesis in a dose-dependent manner with IC50 of 8.7 +/- 2.0 microM and 53.9 +/- 8.5 nM, respectively. Time course studies revealed that the two PI 3-kinase inhibitors blocked VSMC proliferation in mid-late G1 phase, about 6 h before the G1/S transition. This G1 growth arrest was due, at least in part, to the reduction of the CDK2 associated kinase activity resulting mainly from the upregulation of the inhibitory protein p27KIP1.

References

Jan 1, 1994·Pharmacology & Therapeutics·M Sanders
Nov 18, 1994·Cell·C J Sherr
Jul 18, 1994·Biochimica Et Biophysica Acta·M J Fry
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·S RocheS A Courtneidge
Dec 24, 1993·Science·S van den Heuvel, E Harlow
Apr 1, 1993·The Journal of Cell Biology·M PaganoG Draetta
May 13, 1993·Nature·H A LaneG Thomas
Apr 1, 1996·Current Opinion in Cell Biology·C L Carpenter, L C Cantley
Jun 1, 1996·Current Opinion in Immunology·R T Abraham

❮ Previous
Next ❯

Citations

Sep 1, 1999·European Journal of Biochemistry·A BessonV W Yong
Oct 15, 2008·Annual Review of Physiology·Omar Tliba, Reynold A Panettieri
Oct 6, 2000·American Journal of Respiratory Cell and Molecular Biology·K PageM B Hershenson
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·D M Li, H Sun
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·H SunH Wu
Apr 25, 2000·Journal of Molecular and Cellular Cardiology·J AbramowitzJ C Allen
Mar 26, 2003·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Koichi KitamuraShigeo Ohno
Aug 17, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·K Roovers, R K Assoian
May 30, 2002·Science's STKE : Signal Transduction Knowledge Environment·Nancy Olashaw, W J Pledger
Apr 29, 2006·Journal of Cellular Biochemistry·Paul DélérisMonique Breton-Douillon
Apr 4, 2007·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Vera P Krymskaya
Dec 5, 2002·Physiological Genomics·Yasushi HoshikawaMark W Geraci
Apr 17, 2001·The Journal of Biological Chemistry·D BacquevilleM Breton-Douillon
Apr 10, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Marco MuraJohn T Granton
Jul 17, 1999·The American Journal of Physiology·V P KrymskayaR A Panettieri
Apr 22, 1999·General Pharmacology·L Gamet-PayrastreB Payrastre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Cycle Pathways

Cell cycle is a complex process regulated by several signal transduction pathways and enzymes. Here is the latest research on regulation of cell cycle and cell cycle pathways.